Rancho Cordova, California (PRWEB) December 30, 2013
Health science companies are becoming increasingly concerned with the exorbitant labor costs and quality issues created by document scanning and related manual paper-based processes. As companies learn more about the cost of digitizing paper documents, Scan is becoming the industry’s new four-letter word.
To help BioPharma companies quantify the true cost of manual paper-based processes, such as scanning, tagging, and paper archiving, SureClinical announced today that it’s making available 'Estimating Trial Master File Costs,' a new white paper. Besides this free report, SureClinical is also offering its health science cloud-consulting service to help companies evaluate, design, and implement collaborative cloud computing solutions for content management.
As health science companies increasingly move from paper to electronic systems, many important regulatory documents, contracts, and workflows still utilize wet ink signatures on hardcopy documents. Hardcopy paper documents are sent by overnight delivery for signature, shipped back overnight, manually scanned and tagged, and then archived in electronic document management systems. Companies that thought moving from paper to electronic systems would save money are increasingly finding that significant costs are involved in scanning, tagging, and processing paper.
When health science companies signed up to “go electronic” to eliminate paper by digitizing paper documents, many of them didn’t realize the significant investment in labor, software, and scanning equipment that would be required. Digitizing documents is an extremely labor-intensive process that typically requires human labor to review, classify, and tag documents. Just one error during the scanning and tagging process can result in lost documents and quality issues that can impact many related business processes.
Instead of hurling four-letter invectives over the increased cost due to scanning and digitizing paper, organizations in healthcare and BioPharma are looking to replace scanning with cloud digital signing and cloud collaboration technologies. Cloud digital signing technologies enable electronic document completion and capture at the point of document origination, eliminating the need for costly scanning processes and accelerating document completion.
For example, in the clinical trials area, a new standards initiative called the Electronic Trial Master File Standard aims to provide support for cloud-based digital signing of documents as well as support for cloud-based document exchange and collaboration.
In healthcare, a new standard and system known as the Electronic Submission of Medical Documentation System (EsMD) eliminates the need for mailing paper medical bill authorizations and costly scanning and tagging in the US Medicare program. By using digital signing along with a secure cloud system that links healthcare providers with payors, the new EsMD initiative will eliminate the need for costly document scanning, reduce manual coding and tagging, and also reduce the number of fraudulent documents.
SureClinical, a start-up firm in the health science applications area, is one of the first companies to offer health science application solutions that use a secure collaborative cloud approach to content management. SureClinical’s Certified Cloud includes integrated document completion and signing and archiving for networks of health science organizations that wish to share documents in an automated, yet regulated cloud environment.
Headquartered in Northern California, SureClinical is the premier provider of health science content management software applications for BioPharma. SureClinical’s mobile health science content management solutions run on Android®, Apple® iPad, Apple® IOS, and other popular smartphone platforms, as well as on all major web browsers. For more information, visit http://www.SureClinical.com.
Copyright © 2013 SureClinical. All rights reserved. SureClinical, SureEsign, SureTrial, Certified Cloud, and the SureTrial logo are trademarks of SureClinical. Other names used herein may be trademarks of their respective owners.